- Home
- ADTN vs ABSI Comparison
ADTN vs ABSI Comparison
Compare ADTN & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADTN | ABSI |
|---|---|---|
| Founded | 1985 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 997.8M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ADTN | ABSI |
|---|---|---|
| Price | $13.44 | $10.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $15.50 | $6.96 |
| AVG Volume (30 Days) | 1.9M | ★ 7.9M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.83 | 10.64 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,083,807,000.00 | $4,534,000.00 |
| Revenue This Year | $11.09 | $215.96 |
| Revenue Next Year | $8.47 | $319.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.46 | N/A |
| 52 Week Low | $7.11 | $2.24 |
| 52 Week High | $19.98 | $12.06 |
Technical Indicators
Market Signals| Indicator | ADTN | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 60.94 |
| Support Level | $8.72 | $2.80 |
| Resistance Level | $18.34 | $12.06 |
| Average True Range (ATR) | 0.75 | 1.11 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 31.04 | 68.41 |
Price Performance
Historical ComparisonAbout ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.